347 related articles for article (PubMed ID: 23812247)
1. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
[TBL] [Abstract][Full Text] [Related]
3. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
Haghikia A; Schwab J; Vogel-Claussen J; Berliner D; Pfeffer T; König T; Zwadlo C; Moulig VA; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kühl U; Podewski E; Kindermann I; Böhm M; Sliwa K; Hilfiker-Kleiner D; Bauersachs J
Clin Res Cardiol; 2019 Mar; 108(3):290-297. PubMed ID: 30121697
[TBL] [Abstract][Full Text] [Related]
5. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
6. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.
Hilfiker-Kleiner D; Haghikia A; Masuko D; Nonhoff J; Held D; Libhaber E; Petrie MC; Walker NL; Podewski E; Berliner D; Bauersachs J; Sliwa K
Eur J Heart Fail; 2017 Dec; 19(12):1723-1728. PubMed ID: 28345302
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM).
Hoevelmann J; Muller E; Azibani F; Kraus S; Cirota J; Briton O; Ntsekhe M; Ntusi NAB; Sliwa K; Viljoen CA
Clin Res Cardiol; 2021 Aug; 110(8):1259-1269. PubMed ID: 33555408
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
10. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
[TBL] [Abstract][Full Text] [Related]
11. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
[TBL] [Abstract][Full Text] [Related]
12. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
Farhan HA; Yaseen IF
ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K
Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.
Kryczka KE; Demkow M; Dzielińska Z
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254703
[TBL] [Abstract][Full Text] [Related]
16. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies.
Ricke-Hoch M; Pfeffer TJ; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Mar; 116(3):520-531. PubMed ID: 31605117
[TBL] [Abstract][Full Text] [Related]
17. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
Mujkanovic J; Qayyum AA
Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
[TBL] [Abstract][Full Text] [Related]
18. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome.
Ersbøll AS; Johansen M; Damm P; Rasmussen S; Vejlstrup NG; Gustafsson F
Eur J Heart Fail; 2017 Dec; 19(12):1712-1720. PubMed ID: 28597481
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
[TBL] [Abstract][Full Text] [Related]
20. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S
Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
